AnaptysBio's total assets for Q1 2026 were $329.68M, a decrease of -9.53% from the previous quarter. ANAB total liabilities were $316.94M for the fiscal quarter, a -3.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.